1. Hypertension meets osteoarthritis — revisiting the vascular aetiology hypothesis
   Karen Ching et al, 2021, Nature Reviews Rheumatology CrossRef
2. Pharmaceutical therapeutics for articular regeneration and restoration: state-of-the-art technology for screening small molecular drugs
   Yishan Chen et al, 2021, Cellular and Molecular Life Sciences CrossRef
3. Non-Surgical Management of Pre-Arthritic Dysplastic Hip Pain
   Kamal Bali et al, 2020, Hip Dysplasia CrossRef
4. Mechanisms Involved in Superiority of Angiotensin Receptor Blockade over ACE Inhibition in Attenuating Neuropathic Pain Induced in Rats
   Nora Hegazy et al, 2020, Neurotherapeutics CrossRef
5. Advanced Progress of the Relationship Between Antihypertensive Drugs and Bone Metabolism
   Ruixing Zhang et al, 2023, Hypertension CrossRef
6. Renin-angiotensin system in osteoarthritis: A new potential therapy
   Yuangang Wu et al, 2019, International Immunopharmacology CrossRef
7. Angiotensin II triggers knee joint lesions in experimental osteoarthritis
   Grazielle A. de Sá et al, 2021, Bone CrossRef
8. Mechanisms and Molecular Targets of BuShenHuoXue Formula for Osteoarthritis
   Wen Xiong et al, 2022, ACS Omega CrossRef
9. Promising results of captopril in improving knee arthrofibrosis and cartilage status: an animal model study
   Seyed Ali Hashemi et al, 2022, Journal of Experimental Orthopaedics CrossRef
10. Molecular Basic of Pharmacotherapy of Cytokine Imbalance as a Component of Intervertebral Disc Degeneration Treatment
    Natalia A. Shnayder et al, 2023, International Journal of Molecular Sciences CrossRef
11. Aliskiren, tadalafil, and cinnamaldehyde alleviate joint destruction biomarkers; MMP-3 and RANKL; in complete Freund's adjuvant arthritis model: Downregulation of IL-6/JAK2/STAT3 signaling pathway
    Amany A. Azouz et al, 2020, Saudi Pharmaceutical Journal CrossRef
12. Synovial fluid peptidase activity as a biomarker for knee osteoarthritis clinical progression
    Jesús Seco-Calvo et al, 2020, Bone & Joint Research CrossRef